Infographic – Role of the Paul-Ehrlich-Institut in Vaccine Supply Shortages
Role of the Paul-Ehrlich-Institut in Vaccine Supply Shortages
A supply shortage exists when a manufacturer does not have sufficient supplies to deliver orders for more than two weeks or cannot meet an unexpected increase in demand due to increased delivery quantities.
The Paul-Ehrlich-Institut provides information about which human vaccine products or packaging sizes are not available or not available in sufficient quantities for delivery from the manufacturer and how long the supply shortage could potentially last.
- Publication of instructions for action and vaccine alternatives
- Receipt of notifications and categorisation of supply shortages
- Communication with manufacturers, BMG, RKI, EMA office
3 Categories of Supply Shortages and Corresponding Measures
Category 1
- Shortage: individual packaging sizes not available, one or more other packaging sizes available
Publication of information on missing or available packaging
Category 2
- Product supply shortage affects all packaging sizes
- Equivalent alternative vaccine product is available
Publication of the reported supply shortages of affected human vaccine products
plus:
List of alternative vaccine products
Category 3
- Product supply shortage: Alternative vaccine product is not available
- Supply shortage concerns one vaccine product and all equivalent alternative vaccine products
Publication of the reported supply shortages of affected human vaccine products
plus:
Link to recommendations for action by RKI/STIKO: e.g. prioritisation of a risk group with regard to a specific vaccination and additional flexibility of vaccination intervals
